Therapeutic potential of stem cell in liver regeneration

doi:10.1007/s11684-011-0107-0

Front Med

2011, Vol. 5

Issue (1) : 26-32 https://doi.org/10.1007/s11684-011-0107-0

REVIEW

Therapeutic potential of stem cell in liver regeneration

Jinzheng LI, Min LI, Bolin NIU, Jianping GONG(

)

Chongqing Key Laboratory of Hepatobiliary Surgery and Department of Hepatobiliary Surgery, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China

Download: PDF(116 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Liver transplantation is the only life-saving procedure for patients with end-stage liver disease. However, its potential benefits are hampered by many disadvantages, such as the relative shortage of donors, operative risks, and high costs. These issues have prompted the search for new alternative therapies for irreversible liver disease. Stem cell therapy, with the ability for self-renewal and potential for multilineage differentiation, is a promising alternative approach. Several studies have demonstrated that transplantation of hepatic stem/progenitor cells or hepatocyte-like cells derived from multipotent stem cells leads to donor cell-mediated repopulation of the liver and improved survival rates in experimental models of liver disease. However, a registered clinical application based on stem cell technology will take at least an additional 5 to 10 years because of some limitations; e.g. the lack of suitable cell sources and risk of teratoma formation. This review summarizes the general understanding of the therapeutic potentials of stem cells in liver disease, including the sources, mechanisms, and delivery methods of hepatic stem cells in liver regeneration, and discusses some challenges for their therapeutic application.

Keywords stem cell liver disease regenerative medicine

Corresponding Author(s): GONG Jianping,Email:gongjianping11@126.com

Issue Date: 05 March 2011

Cite this article:

Jinzheng LI,Min LI,Bolin NIU, et al. Therapeutic potential of stem cell in liver regeneration[J]. Front Med, 2011, 5(1): 26-32.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-011-0107-0
https://academic.hep.com.cn/fmd/EN/Y2011/V5/I1/26

1	O’Leary J G, Lepe R, Davis G L. Indications for liver transplantation. Gastroenterology , 2008, 134(6): 1764-1776 doi: 10.1053/j.gastro.2008.02.028 pmid:18471553
2	Kung J W, Forbes S J. Stem cells and liver repair. Curr Opin Biotechnol , 2009, 20(5): 568-574 doi: 10.1016/j.copbio.2009.09.004 pmid:19837579
3	Ogawa S, Miyagawa S. Potentials of regenerative medicine for liver disease. Surg Today , 2009, 39(12): 1019-1025 doi: 10.1007/s00595-009-4056-z pmid:19997795
4	Ehnert S, Glanemann M, Schmitt A, Vogt S, Shanny N, Nussler N C, St?ckle U, Nussler A. The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg , 2009, 394(6): 985-997 doi: 10.1007/s00423-009-0546-0 pmid:19644703
5	Alison M R, Islam S, Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol , 2009, 217(2): 282-298 doi: 10.1002/path.2453 pmid:18991329
6	Fausto N, Campbell J S, Riehle K J. Liver regeneration. Hepatology , 2006, 43 (Suppl 1): S45-S53 doi: 10.1002/hep.20969 pmid:16447274
7	Roskams T A, Theise N D, Balabaud C, Bhagat G, Bhathal P S, Bioulac-Sage P, Brunt E M, Crawford J M, Crosby H A, Desmet V, Finegold M J, Geller S A, Gouw A S, Hytiroglou P, Knisely A S, Kojiro M, Lefkowitch J H, Nakanuma Y, Olynyk J K, Park Y N, Portmann B, Saxena R, Scheuer P J, Strain A J, Thung S N, Wanless I R, West A B. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology , 2004, 39(6): 1739-1745 doi: 10.1002/hep.20130 pmid:15185318
8	Dorrell C, Grompe M. Liver repair by intra- and extrahepatic progenitors. Stem Cell Rev , 2005, 1(1): 61-64 doi: 10.1385/SCR:1:1:061 pmid:17132876
9	Lee J S, Heo J, Libbrecht L, Chu I S, Kaposi-Novak P, Calvisi D F, Mikaelyan A, Roberts L R, Demetris A J, Sun Z, Nevens F, Roskams T, Thorgeirsson S S. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med , 2006, 12(4): 410-416 doi: 10.1038/nm1377 pmid:16532004
10	Tanaka M, Okabe M, Suzuki K, Kamiya Y, Tsukahara Y, Saito S, Miyajima A. Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev , 2009, 126(8-9): 665-676 doi: 10.1016/j.mod.2009.06.939 pmid:19527784
11	Okabe M, Tsukahara Y, Tanaka M, Suzuki K, Saito S, Kamiya Y, Tsujimura T, Nakamura K, Miyajima A. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development , 2009, 136(11): 1951-1960 doi: 10.1242/dev.031369 pmid:19429791
12	Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao H L, Moss N, Melhem A, McClelland R, Turner W, Kulik M, Sherwood S, Tallheden T, Cheng N, Furth M E, Reid L M. Human hepatic stem cells from fetal and postnatal donors. J Exp Med , 2007, 204(8): 1973-1987 doi: 10.1084/jem.20061603 pmid:17664288
13	Sangan C B, Tosh D. Hepatic progenitor cells. Cell Tissue Res , 2010, 342(2): 131-137 doi: 10.1007/s00441-010-1055-8 pmid:20957497
14	Oertel M, Menthena A, Dabeva M D, Shafritz D A. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology , 2006, 130(2): 507-520 doi: 10.1053/j.gastro.2005.10.049 pmid:16472603
15	Oertel M, Menthena A, Chen Y Q, Teisner B, Jensen C H, Shafritz D A. Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology , 2008, 134(3): 823-832 pmid:18262526
16	Mahieu-Caputo D, Allain J E, Branger J, Coulomb A, Delgado J P, Andreoletti M, Mainot S, Frydman R, Leboulch P, Di Santo J P, Capron F, Weber A. Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther , 2004, 15(12): 1219-1228 doi: 10.1089/hum.2004.15.1219 pmid:15684698
17	Kallis Y N, Alison M R, Forbes S J. Bone marrow stem cells and liver disease. Gut , 2007, 56(5): 716-724 doi: 10.1136/gut.2006.098442 pmid:17145739
18	Petersen B E, Bowen W C, Patrene K D, Mars W M, Sullivan A K, Murase N, Boggs S S, Greenberger J S, Goff J P. Bone marrow as a potential source of hepatic oval cells. Science , 1999, 284(5417): 1168-1170 doi: 10.1126/science.284.5417.1168 pmid:10325227
19	Gilchrist E S, Plevris J N. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl , 2010, 16(2): 118-129 doi: 10.1002/lt.21965 pmid:20104479
20	Houlihan D D, Newsome P N. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology , 2008, 135(2): 438-450 doi: 10.1053/j.gastro.2008.05.040 pmid:18585384
21	Levicar N, Pai M, Habib N A, Tait P, Jiao L R, Marley S B, Davis J, Dazzi F, Smadja C, Jensen S L, Nicholls J P, Apperley J F, Gordon M Y. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif , 2008, 41 (Suppl 1): 115-125 doi: 10.1111/j.1365-2184.2008.00491.x pmid:18181952
22	Tajima F, Tsuchiya H, Nishikawa K, Kataoka M, Hisatome I, Shiota G. Hepatocyte growth factor mobilizes and recruits hematopoietic progenitor cells into liver through a stem cell factor-mediated mechanism. Hepatol Res , 2010, 40(7): 711-719 doi: 10.1111/j.1872-034X.2010.00647.x pmid:20557370
23	Yamaguchi K, Itoh K, Masuda T, Umemura A, Baum C, Itoh Y, Okanoue T, Fujita J. In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivo. J Hepatol , 2006, 45(5): 681-687 doi: 10.1016/j.jhep.2006.04.012 pmid:16837099
24	Friedenstein A J, Chailakhjan R K, Lalykina K S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet , 1970, 3(4): 393-403 pmid:5523063
25	Lee K D, Kuo T K, Whang-Peng J, Chung Y F, Lin C T, Chou S H, Chen J R, Chen Y P, Lee O K. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology , 2004, 40(6): 1275-1284 doi: 10.1002/hep.20469 pmid:15562440
26	Liu Z J, Zhuge Y, Velazquez O C. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem , 2009, 106(6): 984-991 doi: 10.1002/jcb.22091 pmid:19229871
27	Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T, Brulport M, Hengstler J G, Dollinger M M, Fleig W E, Christ B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut , 2009, 58(4): 570-581 doi: 10.1136/gut.2008.154880 pmid:19022918
28	Cho K A, Ju S Y, Cho S J, Jung Y J, Woo S Y, Seoh J Y, Han H S, Ryu K H. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int , 2009, 33(7): 772-777 doi: 10.1016/j.cellbi.2009.04.023 pmid:19427913
29	Kuo T K, Hung S P, Chuang C H, Chen C T, Shih Y R, Fang S C, Yang V W, Lee O K. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology , 2008; 134(7):2111-2121, 2121.e1-3
30	Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology , 2007, 46(1): 219-228 doi: 10.1002/hep.21704 pmid:17596885
31	Wang Z, Lu H, Wang Y C, Cong X Q. Human embryonic stem cells and liver diseases: from basic research to future clinical application. J Dig Dis , 2008, 9(1): 14-19 doi: 10.1111/j.1443-9573.2007.00319.x pmid:18251789
32	Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, Meng S, Chen Y, Zhou R, Song X, Guo Y, Ding M, Deng H. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology , 2007, 45(5): 1229-1239 doi: 10.1002/hep.21582 pmid:17464996
33	Dan Y Y, Yeoh G C. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol , 2008, 23(5): 687-698 doi: 10.1111/j.1440-1746.2008.05383.x pmid:18410603
34	Dalgetty D M, Medine C N, Iredale J P, Hay D C. Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol , 2009, 297(2): G241-G248 doi: 10.1152/ajpgi.00138.2009 pmid:19520740
35	Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell , 2006, 126(4): 663-676 doi: 10.1016/j.cell.2006.07.024 pmid:16904174
36	Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature , 2007, 448(7151): 313-317 doi: 10.1038/nature05934 pmid:17554338
37	Yu J, Vodyanik M A, Smuga-Otto K, Antosiewicz-Bourget J, Frane J L, Tian S, Nie J, Jonsdottir G A, Ruotti V, Stewart R, Slukvin I I, Thomson J A. Induced pluripotent stem cell lines derived from human somatic cells. Science , 2007, 318(5858): 1917-1920 doi: 10.1126/science.1151526 pmid:18029452
38	Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein B E, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature , 2007, 448(7151): 318-324 doi: 10.1038/nature05944 pmid:17554336
39	Lowry W E, Richter L, Yachechko R, Pyle A D, Tchieu J, Sridharan R, Clark A T, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA , 2008, 105(8): 2883-2888 doi: 10.1073/pnas.0711983105 pmid:18287077
40	Park I H, Zhao R, West J A, Yabuuchi A, Huo H, Ince T A, Lerou P H, Lensch M W, Daley G Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature , 2008, 451(7175): 141-146 doi: 10.1038/nature06534 pmid:18157115
41	Kim J B, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo M J, Ruau D, Han D W, Zenke M, Sch?ler H R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature , 2008, 454(7204): 646-650 doi: 10.1038/nature07061 pmid:18594515
42	Carey B W, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA , 2009, 106(1): 157-162 doi: 10.1073/pnas.0811426106 pmid:19109433
43	Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T, Hao E, Hayek A, Deng H, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell , 2009, 4(1): 16-19 doi: 10.1016/j.stem.2008.11.014 pmid:19097958
44	Theise N D, Nimmakayalu M, Gardner R, Illei P B, Morgan G, Teperman L, Henegariu O, Krause D S. Liver from bone marrow in humans. Hepatology , 2000, 32(1): 11-16 doi: 10.1053/jhep.2000.9124 pmid:10869283
45	Alison M R, Poulsom R, Jeffery R, Dhillon A P, Quaglia A, Jacob J, Novelli M, Prentice G, Williamson J, Wright N A. Hepatocytes from non-hepatic adult stem cells. Nature , 2000, 406(6793): 257 doi: 10.1038/35018642 pmid:10917519
46	Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, Sato T, Miyanishi K, Takayama T, Takahashi M, Takimoto R, Iyama S, Matsunaga T, Ohtani S, Matsuura A, Hamada H, Niitsu Y. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood , 2005, 106(2): 756-763 doi: 10.1182/blood-2005-02-0572 pmid:15817682
47	Jang Y Y, Collector M I, Baylin S B, Diehl A M, Sharkis S J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol , 2004, 6(6): 532-539 doi: 10.1038/ncb1132 pmid:15133469
48	Willenbring H, Bailey A S, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming W H, Grompe M. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med , 2004, 10(7): 744-748 doi: 10.1038/nm1062 pmid:15195088
49	Quintana-Bustamante O, Alvarez-Barrientos A, Kofman A V, Fabregat I, Bueren J A, Theise N D, Segovia J C. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology , 2006, 43(1): 108-116 doi: 10.1002/hep.21005 pmid:16374873
50	Rodi? N, Rutenberg M S, Terada N. Cell fusion and reprogramming: resolving our transdifferences. Trends Mol Med , 2004, 10(3): 93-96 doi: 10.1016/j.molmed.2004.01.010 pmid:15106589
51	Dahlke M H, Popp F C, Larsen S, Schlitt H J, Rasko J E. Stem cell therapy of the liver—fusion or fiction? Liver Transpl , 2004, 10(4): 471-479 doi: 10.1002/lt.20121 pmid:15048788
52	Camargo F D, Finegold M, Goodell M A. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest , 2004, 113(9): 1266-1270 pmid:15124017
53	Krause P, Saghatolislam F, Koenig S, Unthan-Fechner K, Probst I. Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells. In Vitro Cell Dev Biol Anim , 2009, 45(5-6): 205-212 doi: 10.1007/s11626-008-9166-1 pmid:19184253
54	Woodrow K A, Wood M J, Saucier-Sawyer J K, Solbrig C, Saltzman W M. Biodegradable meshes printed with extracellular matrix proteins support micropatterned hepatocyte cultures. Tissue Eng Part A , 2009, 15(5): 1169-1179 doi: 10.1089/ten.tea.2008.0265 pmid:19072719
55	Wen F, Chang S, Toh Y C, Arooz T, Zhuo L, Teoh S H, Yu H. Development of dual-compartment perfusion bioreactor for serial coculture of hepatocytes and stellate cells in poly(lactic-co-glycolic acid)-collagen scaffolds. J Biomed Mater Res B Appl Biomater , 2008, 87(1): 154-162 doi: 10.1002/jbm.b.31086 pmid:18431752
56	Jindal R, Nahmias Y, Tilles A W, Berthiaume F, Yarmush M L. Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J , 2009, 23(7): 2288-2298 doi: 10.1096/fj.08-114934 pmid:19246486
57	Xiong A, Austin T W, Lagasse E, Uchida N, Tamaki S, Bordier B B, Weissman I L, Glenn J S, Millan M T. Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells. Tissue Eng Part A , 2008, 14(6): 995-1006 doi: 10.1089/ten.tea.2007.0087 pmid:19230124
58	Hoshiba T, Cho C S, Murakawa A, Okahata Y, Akaike T. The effect of natural extracellular matrix deposited on synthetic polymers on cultured primary hepatocytes. Biomaterials , 2006, 27(26): 4519-4528 doi: 10.1016/j.biomaterials.2006.04.014 pmid:16697038
59	Hoshiba T, Wakejima M, Cho C S, Shiota G, Akaike T. Different regulation of hepatocyte behaviors between natural extracellular matrices and synthetic extracellular matrices by hepatocyte growth factor. J Biomed Mater Res A , 2008, 85(1): 228-235 doi: 10.1002/jbm.a.31571 pmid:17688272
60	Hidaka M, Su G N, Chen J K, Mukaisho K, Hattori T, Yamamoto G. Transplantation of engineered bone tissue using a rotary three-dimensional culture system. In Vitro Cell Dev Biol Anim , 2007, 43(2): 49-58 doi: 10.1007/s11626-006-9005-1 pmid:17570019
61	Chen Z, Qi L Z, Zeng R, Li H Y, Dai L J. Stem cells and hepatic cirrhosis. Panminerva Med , 2010, 52(2): 149-165 pmid:20517197
62	Russo F P, Alison M R, Bigger B W, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale J P, Forbes S J. The bone marrow functionally contributes to liver fibrosis. Gastroenterology , 2006, 130(6): 1807-1821 doi: 10.1053/j.gastro.2006.01.036 pmid:16697743

[1]	Ling Wang, Lining Wang, Xing Fan, Wei Tang, Jiong Hu. Fludarabine and intravenous busulfan conditioning with post-transplantation cyclophosphamide for allogeneic peripheral stem cell transplantation for adult patients with lymphoid malignancies: a prospective single-arm phase II study[J]. Front. Med., 2021, 15(1): 108-115.
[2]	Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu, Qiang Zhang, Xiaowei Xu, Hainv Gao, Xiaojun Wu, Dong Li, Wanli Jiang, Jingjing Qu, Charlie Xiang, Lanjuan Li. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19[J]. Front. Med., 2020, 14(5): 664-673.
[3]	Xuran Chu, Chengshui Chen, Chaolei Chen, Jin-San Zhang, Saverio Bellusci, Xiaokun Li. Evidence for lung repair and regeneration in humans: key stem cells and therapeutic functions of fibroblast growth factors[J]. Front. Med., 2020, 14(3): 262-272.
[4]	Xiaolin Fan, Yanzhen Xiong, Yuan Wang. A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications[J]. Front. Med., 2019, 13(5): 531-539.
[5]	Lijuan Hu, Qi Wang, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Kaiyan Liu, Hui Wang, Xiaojun Huang, Xiaodong Mo. Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation[J]. Front. Med., 2019, 13(4): 492-503.
[6]	Xiaodong Mo, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang. Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation[J]. Front. Med., 2019, 13(3): 354-364.
[7]	Xiaodong Mo, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang. Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation[J]. Front. Med., 2019, 13(2): 238-249.
[8]	Rui Shi, Yuelong Huang, Chi Ma, Chengai Wu, Wei Tian. Current advances for bone regeneration based on tissue engineering strategies[J]. Front. Med., 2019, 13(2): 160-188.
[9]	Qiming Zhai, Zhiwei Dong, Wei Wang, Bei Li, Yan Jin. Dental stem cell and dental tissue regeneration[J]. Front. Med., 2019, 13(2): 152-159.
[10]	Shihua Wang, Rongjia Zhu, Hongling Li, Jing Li, Qin Han, Robert Chunhua Zhao. Mesenchymal stem cells and immune disorders: from basic science to clinical transition[J]. Front. Med., 2019, 13(2): 138-151.
[11]	Meng Lv, Yingjun Chang, Xiaojun Huang. Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation[J]. Front. Med., 2019, 13(1): 45-56.
[12]	Xiaoqing Li, Xinxin Li, Genbei Wang, Yan Xu, Yuanyuan Wang, Ruijia Hao, Xiaohui Ma. Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice[J]. Front. Med., 2018, 12(6): 688-696.
[13]	Yun Zhang, Robert A. Weinberg. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities[J]. Front. Med., 2018, 12(4): 361-373.
[14]	Meijuan Zheng, Haoyu Sun, Zhigang Tian. Natural killer cells in liver diseases[J]. Front. Med., 2018, 12(3): 269-279.
[15]	Xuefu Wang, Zhigang Tian. γδ T cells in liver diseases[J]. Front. Med., 2018, 12(3): 262-268.

Viewed

Full text

Abstract

Cited

Shared

Discussed